25 results for “amyloid”. Showing 25 of 39,449.
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study.
amyloid-β peptide (Aβ42) levels in cerebrospinal fluid or on amyloid
Depressive Symptoms and Amyloid Pathology.
Amyloid-β1-42 levels in cerebrospinal fluid or amyloid positron
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
amyloid plaque drives pathogenesis of Alzheimer disease (AD). Reduction of amyloid
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.
amyloid β-positivity, referred to here as amyloid age, and in relation
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial.
amyloid clearance. Change in amyloid, tau, and clinical decline after
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.
amyloid beta epitope that is present only in brain amyloid
A three-dimensional human neural cell culture model of Alzheimer's disease.
amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer
iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta.
amyloid clearance. Conversely, APOE2 increased amyloid beta 1-42 (Aβ42
Bacterial amyloids.
amyloids. The general ability of amyloids to bind amyloid-specific
Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment: A Meta-Analysis.
amyloid-positive and amyloid-negative older adults without cognitive impairment
Viruses and amyloids - a vicious liaison.
amyloids and, consequently, amyloid and virus research need to join
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.
amyloid (Aβ)42/Aβ40, as measured by a high-precision
Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET.
amyloid PET progression among initially amyloid PET negative (A-) individuals
Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.
amyloid (cerebral amyloid angiopathy, or CAA) are generally asymptomatic, but in advanced
Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy.
amyloid plaques, the β-amyloid load (volume percent) and the amyloid
Interactions between pathological and functional amyloid: A match made in Heaven or Hell?
amyloid wherever they encounter monomeric amyloid precursors. Amyloid proteins can also
Diversity, biogenesis and function of microbial amyloids.
amyloids leading the way. Unlike disease-associated amyloids, functional amyloids
Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
amyloid tracers bind to identical sites on amyloid-β fibrils
Guinea pigs as a nontransgenic model for APP processing in vitro and in vivo.
amyloid plaque formation, the composition of beta-amyloid plaques, and the accompanying
Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease.
amyloid-targeting therapy that resulted in robust amyloid plaque reduction
The bacterial chaperone CsgC inhibits functional amyloid CsgA formation by promoting the intrinsically disordered pre-nuclear state.
amyloid called curli during biofilm formation. The major curlin subunit
AGEs RAGE Pathways: Alzheimer's Disease.
amyloid peptide (Aβ). The β-amyloid peptide (Aβ) that results
[Cholesterol and Alzheimer's disease].
amyloid precursor protein. The compartmentation of the amyloid precursor protein
Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
amyloid polyneuropathy (FAP ATTR Val30Met) cases unrelated to endemic foci
Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection.
amyloid mAbs consistently demonstrated robust amyloid clearance and modest slowing